LIPELLA PHARMACEUTICALS INC. research brief
CIK 1347242
Generated Nov. 17, 2026, 3:36 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: PITTSBURGH Pennsylvania. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- April 1, 2025 · D · 0001753926-25-000541 · Source evidence
Reported offering amount: 9000 USD. Reported amount sold: 9000 USD.
- Jan. 7, 2025 · D · 0001753926-25-000060 · Source evidence
Reported offering amount: 6000000 USD. Reported amount sold: 2597500 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “LIPELLA PHARMACEUTICALS INC. research brief,” CIK 1347242, retrieved Nov. 17, 2026, 3:36 p.m.. Cite the specific accessions used. No amounts have been summed.